{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "CBZ",
  "name": "CBIZ, Inc.",
  "url": "https://orbyd.app/dossiers/CBZ/",
  "json_url": "https://orbyd.app/dossiers/CBZ.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Activist-driven re-rate on a cheap professional-services roll-up: Reference Equity's July 7 letter to halt buybacks and resume M&A drove a +9.3% pop, and the tape is +36% in 30 days straight into a July 29 earnings binary that confirms or breaks the story.",
  "invalidation_trigger": "A weekly close below $36 surrenders the post-activist-letter breakout base and signals the re-rate leg failed; secondarily, a July 29 Q2 revenue miss under $704.9M or a FY guide cut below $4.00 EPS confirms the break.",
  "catalyst_date": "2026-07-29",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "semi-foundry-equipment",
    "m-and-a-special-situations",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "EARNINGS BLACKOUT: Q2/first-half 2026 prints 2026-07-29 after close, call 5:00pm ET binary; avoid fresh entries into the print (consensus EPS $0.81, rev $704.9M, FY bar $4.00-4.10 EPS).",
    "THEME MIS-TAG: seeded 'managed-care-health-services' is wrong CBIZ is a professional-services / accounting-advisory firm (Marcum roll-up) with a benefits & insurance segment, not a managed-care name.",
    "Activist: Reference Equity (long-only, PM Ryan Bunn), letter+deck 2026-07-07 halt buybacks, resume M&A, raise equity. Stock +9.3% on disclosure.",
    "Valuation: ~10.4x forward / ~14-17x TTM P/E vs accounting-advisory peers 22-29x; consensus PT ~$42.60 sits at spot. 52-week range $24.29-$77.91, -43% over 12 months."
  ],
  "body_markdown": "## Current Thesis\nActivist-driven re-rate on a cheap professional-services roll-up. Reference Equity's July 7 letter to halt buybacks and resume the M&A engine drove a +9.3% pop, and the tape is +36% in 30 days straight into a July 29 earnings binary that either confirms the growth-restoring story or reprices the whole move. The multiple is genuinely cheap (~10.4x forward vs peers 22–29x), but the setup is stretched into a catalyst it cannot yet see, and consensus price target already sits at spot.\n\n## Bull Case\n- Activist campaign is live and specific: Reference Equity (long-only, PM Ryan Bunn) published a July 7, 2026 letter + deck demanding CBIZ halt share repurchases, resume the acquisition program, and raise equity to fund growth. Stock +9.3% on disclosure; Bloomberg and Bloomberg Tax covered it July 7.\n- Valuation gap is the entire pitch: ~14–17x trailing P/E and ~10.4x forward vs accounting/advisory peers at 22–29x. Any move toward a peer multiple is a large re-rate.\n- Guidance sits above the street: FY2026 guide of EPS $4.00–4.10 vs consensus $3.79, revenue $2.8–2.9B (issued ~May 1, 2026).\n- Post-Marcum scale is showing in the numbers: TTM revenue +28.3% YoY, net income +77.5% YoY.\n- Recovery momentum: +36.4% over 30 days and +38.8% over 90 days into $42.63 on July 24 (+5.9% that session).\n\n## Bear Case\n- Binary earnings in 3 trading days: Q2/first-half print July 29 after close (call 5:00pm ET), consensus Q2 EPS $0.81 and revenue $704.9M. A miss on Marcum pricing or integration reprices the activist pop instantly.\n- The obvious upside looks captured: consensus PT $42.60 vs price $42.63 mainstream sell-side models roughly zero further room from here.\n- Still a wreck on the tape: −43% over 12 months, 52-week range $24.29–$77.91. The current $42 is a bounce off a crash, not a fresh high.\n- Marcum overhang persists: pricing pressure and elevated post-deal leverage are the exact concerns cited in July 20 valuation-debate coverage. The activist remedy raise equity is itself dilutive.\n- The \"worth over 2x\" and +211% outlier targets (Simply Wall St narrative, nemo.money, July 2026) stand against a consensus target sitting at spot.\n\n## Setup & Price Structure\n- $42.63 on July 24, having reclaimed the low-$30s base (the level ~30 days prior was near $31) after the July 7 activist catalyst.\n- Post-activist breakout base sits ~$36–37 (July 10 traded $37.79 mid-move). That shelf is the line the re-rate leg has to defend.\n- Stretched profile: a +36% 30-day advance running directly into a binary print strength that is an event pop, not a durable accelerating trend.\n- Overhead: the $77.91 52-week high is distant; nearest friction is the round $45–48 zone just above the consensus-target cluster near $42.60.\n\n## Catalyst Calendar (next 30 days)\n- 2026-07-29 (after close): Q2 and first-half 2026 results; call 5:00pm ET. Consensus EPS $0.81, revenue $704.9M, FY bar $4.00–4.10 EPS. This is the binary.\n- Ongoing: Reference Equity campaign watch for a board response, any 13D-style escalation, or an actual M&A restart / capital-raise announcement following the July 7 letter.\n- The reaffirm-or-raise call against the $4.00–4.10 EPS guide is the single number that governs the post-print move.\n\n## What Would Change Our Mind\n- A weekly close below $36 surrenders the post-activist-letter breakout base and signals the re-rate leg has failed, with the July 7 pop round-tripping.\n- A July 29 revenue miss under $704.9M, or a FY guide cut below $4.00 EPS, breaks the growth-restoring leg on the fundamentals.\n- The board rejecting the activist with no acquisition restart removes the special-situation catalyst entirely.\n- Inverted: a clean beat plus guide raise plus an explicit M&A restart converts this from stretched-into-print to a fresh accelerating leg worth engaging on a defined higher-low.\n\n## Correlation Notes\n- Moves with professional-services / accounting-advisory consolidators and staffing-consulting names; sensitive to middle-market client spend and the hiring cycle.\n- The benefits & insurance segment lends partial defensive ballast, but this is not a managed-care or health-services name despite the legacy theme tag carried in from theme discovery.\n- Behaves as an activist special situation: correlated more to event and catalyst flow than to broad-market beta in any given week.\n- Elevated post-Marcum leverage keeps it rate-sensitive; a tightening macro impulse pressures the multiple that the entire bull case depends on.",
  "first_seen": "2026-07-23",
  "last_analyzed": "2026-07-25T07:02:34+00:00",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}